Filing Details
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:ARCT
Arcturus Therapeutics Holdings Inc. (ARCT) Reports Material Event to SEC
Filing Details Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market…
Market Context
Arcturus Therapeutics Holdings Inc.'s stock currently trades at $7.28 with a market capitalization of $233.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Arcturus Therapeutics Holdings Inc.'s stock.
All SEC filings for Arcturus Therapeutics Holdings Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ARCT Stock Page
Frequently Asked Questions
Where can I read ARCT's SEC filings?
Browse all filings on our ARCT SEC filings page.
What types of SEC filings does Arcturus Therapeutics Holdings Inc. file?
Public companies like Arcturus Therapeutics Holdings Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.